What is the likely diagnosis for a 31-year-old individual with a history of health anxiety, experiencing persistent and intense emotional distress, characterized by feelings of torment, weepiness, and dark emotions, despite normal laboratory results, including vitamin D, iron, and B12 levels, and a methylation report showing impaired folate and BH4 cycles, after a course of Sertraline (selective serotonin reuptake inhibitor) and supplementation with 5-Hydroxytryptophan (5-HTP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis

Single most likely diagnosis

  • Anxiety Disorder: The patient's history of health anxiety, agoraphobia, and excessive reassurance seeking behavior are all consistent with an anxiety disorder. The patient's symptoms of emotional distress, torment, weepiness, and dark terrifying emotions are also typical of anxiety disorders.

Other Likely diagnoses

  • Adjustment Disorder: The patient's symptoms of emotional distress and anxiety began after a series of stressful events, including contracting COVID-19, moving to a new apartment, and experiencing a traumatic event (living under barking dogs for six years). Adjustment disorder is a possible diagnosis, as the patient's symptoms may be a response to these stressors.
  • Depressive Disorder: Although the psychiatrist ruled out depression, the patient's symptoms of emotional distress, weepiness, and dark thoughts could be consistent with a depressive disorder. However, the lack of other typical depressive symptoms, such as changes in appetite or sleep, makes this diagnosis less likely.
  • Trauma- and Stressor-Related Disorder: The patient's history of living under barking dogs for six years and experiencing a traumatic event (contracting COVID-19) could contribute to the development of a trauma- and stressor-related disorder, such as post-traumatic stress disorder (PTSD).

Do Not Miss (ddxs that may not be likely, but would be deadly if missed.)

  • Panic Disorder: The patient's symptoms of panic attacks, agoraphobia, and excessive reassurance seeking behavior could be consistent with panic disorder. Although the patient's symptoms are not typical of panic disorder, it is essential to consider this diagnosis due to the potential severity of the condition.
  • Cardiovascular Disease: The patient's history of chest pain and breathlessness, although investigated and found to be non-cardiac, warrants consideration of cardiovascular disease as a potential diagnosis. The patient's excessive reassurance seeking behavior and health anxiety may be contributing to the persistence of these symptoms.

Rare diagnoses

  • Mitochondrial Disease: The patient's symptoms of emotional distress, fatigue (although not reported), and impaired folate and BH4 cycles (MTHFR TT) could be consistent with a mitochondrial disease, such as mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
  • Neurodegenerative Disease: The patient's symptoms of emotional distress, anxiety, and impaired neurotransmitter metabolism (high noradrenaline and low serotonin) could be consistent with a neurodegenerative disease, such as Parkinson's disease or multiple system atrophy. However, the lack of other typical symptoms, such as motor symptoms or cognitive decline, makes this diagnosis less likely.

The therapy session may have triggered the patient's symptoms by:

  • Increasing the patient's awareness of their anxiety and health concerns
  • Providing a sense of temporary relief or hope, followed by a crash or worsening of symptoms
  • Triggering a sense of emotional distress or trauma, which may have contributed to the patient's symptoms

The patient's methylation report and genetic testing results (MTHFR TT, COMT CT, MAOA TT, MAOB GG) may be relevant to their symptoms, as impaired folate and BH4 cycles can contribute to anxiety, depression, and other psychiatric symptoms. The patient's response to 5-HTP, a supplement that increases serotonin levels, may also be relevant, as it provided temporary relief from symptoms. However, the patient's symptoms returned after a bad hangover and vomiting, suggesting that the underlying cause of their symptoms is more complex and multifactorial.

Related Questions

What are the recommended diuretics for oral antihypertensive management in Chronic Kidney Disease (CKD)?
What is the diagnosis for a 5-year-old patient with acute respiratory distress, characterized by difficulty breathing for 2 hours, fever, and cough for 4 days, with a history of Gastroesophageal Reflux Disease (GERD) as an infant, presenting with worsening stridor, agitation, and thick yellow nasal and oropharyngeal discharge?
What is the significance of normal Thyroid-Stimulating Hormone (TSH) and free thyroxine (FT4) levels with elevated free triiodothyronine (FT3) levels?
What is the likely diagnosis for a 31-year-old individual with no family history of neurodegenerative or autoimmune diseases, presenting with persistent emotional distress, torment, weepiness, and dark terrifying emotions, following a history of COVID-19 infection, health anxiety, agoraphobia, and treatment with Sertraline (selective serotonin reuptake inhibitor), despite normal vitamin levels, including vitamin D, iron, and B12, and impaired methylation cycles due to MTHFR (methylenetetrahydrofolate reductase) gene mutation?
What is the likely diagnosis for a 31-year-old individual with no family history of neurodegenerative or autoimmune diseases, presenting with persistent emotional distress, torment, and weepiness, despite normal laboratory results, including vitamin D, iron, B12, magnesium, and calcium levels, and a methylation report showing impaired folate and BH4 cycles, after experiencing COVID-19, health anxiety, agoraphobia, and taking Sertraline (selective serotonin reuptake inhibitor)?
What is the likely diagnosis for a 31-year-old individual with no family history of neurodegenerative or autoimmune diseases, presenting with persistent emotional distress, characterized by unbearable torment, weepiness, and dark terrifying emotions, following a COVID-19 infection, and unresponsive to Sertraline (selective serotonin reuptake inhibitor), with laboratory results showing low folic acid, impaired folate and tetrahydrobiopterin (BH4) cycles due to methylenetetrahydrofolate reductase (MTHFR) mutation, and high noradrenaline and low serotonin levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.